Pharmaceutical composition for the treatment of rheumatic syndromes containing sulfur, mustard seeds and a copper salt
CA 2358474 A1 · Owner: Gschwend, Norbert A. · Inventors: Gschwend, Norbert A.; Gschwend, Norbert
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a pharmaceutical composition for the treatment of rheumatic syndromes, especially rheumatism arthritis, sciatica and/or gout, characterized in that it contains at least the active substances sulfur mustard seeds and a copper salt. The pharmaceutical composition may optionally contain camomile, camphor and/or potassium iodate. Talc is preferably used as carrier substance. The composition is preferably available in the form of a powder, e.g. a foot powder but other forms of administration such as creams ointments and the like are also possible.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 19, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 19, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 19, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.